Itau Unibanco Holding S.A.’s iShares Biotechnology ETF IBB Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-215,095	Closed	-$29.2M	–	234
2023 Q4	$29.2M	Sell	215,095 -179,390	-45%	-$21.9M	0.96%	25
2023 Q3	$48.2M	Buy	+394,485	New	+$50.2M	2.13%	12
2023 Q1	–	Sell	-339,976	Closed	-$44.7M	–	551
2022 Q4	$44.7M	Buy	339,976 +96,371	+40%	+$12.5M	1.81%	16
2022 Q3	$28.5M	Buy	243,605 +212,608	+686%	+$26.4M	1.14%	21
2022 Q2	$3.65M	Buy	30,997 +10,819	+54%	+$1.28M	0.13%	93
2022 Q1	$2.63M	Buy	+20,178	New	+$2.63M	0.07%	98
2017 Q2	–	Sell	-327	Closed	-$32K	–	706
2017 Q1	$32K	Buy	+327	New	+$31.3K	﹤0.01%	296

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Itau Unibanco Holding S.A.'s IBB Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 215,095 shares — an estimated $29.2M sold.

Itau Unibanco Holding S.A. first reported a position in IBB in Q1 2017 and held it in 7 quarters. The position peaked at $48.2M in Q3 2023. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

Itau Unibanco Holding S.A. reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 215,095 iShares Biotechnology ETF shares in Q1 2024, an estimated $29.2M.
Itau Unibanco Holding S.A. first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 7 quarters.
Itau Unibanco Holding S.A.'s iShares Biotechnology ETF position peaked at $48.2M in Q3 2023.
899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.